ALX-009

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameALX-009
Drug Alias Namehypothiocyanite + bovine lactoferrin(Alaxia)ALX-009
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBronchiectasisCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlaxia Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlaxia Sas
Active IndicationsN/A
Inactive IndicationsBronchiectasisCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A